Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson's disease. Molecular Formula: C12H13N Solubility: Chloroform (Slightly), Methanol (Slightly) Molecular Weight: 171.24